Riehl melanosis - Riehl Melanozihttps://en.wikipedia.org/wiki/Riehl_melanosis
Riehl Melanozi (Riehl melanosis) - qichima, eritema va pigmentatsiya bilan boshlanadigan kontakt dermatitning bir shakli bo'lib, asta-sekin tarqalib, ma'lum darajaga yetgandan so'ng, statsionar holga keladi. Ba'zi parfyumeriya yoki kremlardan foydalangandan keyin quyoshga ta'sir qilish kasallikning sababi bo'lishi mumkin.

☆ Germaniyaning 2022 yilgi Stiftung Warentest natijalariga ko'ra, iste'molchilarning ModelDermdan qoniqish darajasi pullik teletibbiyot maslahatlariga qaraganda bir oz pastroq bo'lgan.
      References Riehl Melanosis 32491369 
      NIH
      Riehl melanosis ko'pincha pigmentli kontakt dermatit sifatida tanilgan. Bu odatda kosmetika mahsulotlarida mavjud bo'lgan xushbo'y hid va boshqa moddalar tomonidan qo'zg'atiladigan allergiya tufayli yuzaga keladigan teri kasalligining bir turi. Dermatitning bir turi sifatida tasniflanishiga qaramay, Riehl melanosis teridagi pigmentatsiya o'zgarishlarini ko'rsatadi, faqat kichik tirnash xususiyati belgilari bilan. Bu ko'proq qora tanli odamlarda uchraydi. So'nggi tadqiqotlar Riehl melanosis bilan bog'liq chuqur pigmentatsiyani bartaraf etish uchun mid-fluence QSNY 1064-nm lazer bilan davolash samaradorligini o'rganib chiqdi. Boshqa bir tadqiqotda turli xil davolash usullari, jumladan low-fluence 1064-nm Q-switched Nd: YAG lazer, gidroxinon kremi va og'iz traneksamik kislotasi birlashtirildi, bu ko'pchilik bemorlarda sezilarli yaxshilanishga olib keldi.
      Riehl melanosis (RM), commonly called pigmented contact dermatitis, is considered an acquired form of allergic contact dermatitis, typically to fragrance and other ingredients of cosmetic products. Although it is considered as a dermatitis, it presents clinically with hyperpigmentation over the face and shows pigment incontinence with minimal eczematous changes on histology. The condition is more commonly seen in dark-skinned people, causing an important psychosocial impact. A recent study showing the higher effectiveness of mid-fluence QSNY 1064-nm laser in targetting the deep pigmentation of RM has also been conducted. Another study used a combination of therapies to include low-fluence, 1064-nm, Q-switched Nd: YAG laser, hydroquinone cream, and oral tranexamic acid, with the majority of patients experiencing significant improvement.
       Research Advances in the Treatment of Riehl’s Melanosis 37168093 
      NIH
      Riehl's melanosis - ayrim allergenlar bilan aloqa qilish va quyosh nuri ta'sirida yuzaga keladigan teri kasalligining bir turi. Bu terining tez, progressiv kulrang-jigarrang pigmentatsiyasiga olib keladi, bu bemorlarga ham ruhiy, ham jismoniy ta'sir ko'rsatishi mumkin. Riehl's melanosis ning aniq sababi hali noma'lum bo'lsa-da, mavjud tadqiqotlar allergen ta'siri bilan kuchli aloqani ko'rsatadi. Davolash uchun an'anaviy dori vositalari va lazer terapiyasi, ko'pincha teriga qo'llaniladigan oqartiruvchi vositalardan foydalanish bilan bir qatorda sinab ko'rilgan. Lazer terapiyasi, xususan, Q-switched Nd:YAG lazer yordamida, Riehl's melanosis davolash uchun istiqbolli natijalarni ko'rsatdi. Turli xil davolash usullarini birlashtirish ijobiy natijalarga olib keldi.
      Riehl's melanosis (RM) is a contact photodermatitis, with fast progressive gray-brown skin pigmentation as the main manifestation, which can seriously affect the psychology and physiology of patients. Currently, although the etiological factors of Riehl's melanosis is still be unknown, the existing literature proves clearly the cause of it is related to the contacting with suspected allergens. For decades, there has been no standard method for the treatment of RM, but with both conventional drug therapy and laser therapy having been attempted. Topical application of bleaching agents is mainly used as an auxiliary treatment modality. The laser treatment modality remains a hot spot, among which Q-switched Nd:YAG laser is well received for RM. Positive outcomes have been achieved by the combined treatment modalities attempted in recent years also achieve positive outcomes.